Description

BSE announces listing of Commercial Paper worth Rs. 1,300 crore issued by Reliance Industries Ltd on private placement basis, with redemption dates in December 2025.

Summary

BSE has listed two series of Commercial Paper issued by Reliance Industries Ltd on private placement basis, totaling Rs. 1,300 crore (Rs. 1,000 crore + Rs. 300 crore). Both instruments carry CARE A1+ and CRISIL A1+ ratings and will be redeemed in December 2025. Trading commenced on November 17, 2025, on the BSE Debt segment.

Key Points

  • Series 1: 20,000 units of Rs. 5 lakh each (total Rs. 1,000 crore), Scrip Code 730566, ISIN INE002A14LN1
  • Series 2: 6,000 units of Rs. 5 lakh each (total Rs. 300 crore), Scrip Code 730583, ISIN INE002A14LO9
  • Issue Price: Rs. 497,027.50 per unit (Series 1) and Rs. 496,628.50 per unit (Series 2)
  • Both series allotted on November 17, 2025
  • ICICI Bank Limited appointed as Issuing and Paying Agent
  • Trading only in dematerialized form
  • Standard denomination: Rs. 5 lakhs and multiples thereof
  • Tick size: 1 paise

Regulatory Changes

No regulatory changes. This is a standard listing announcement.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under the specified ISIN numbers
  • Trading must be conducted in standard denominations of Rs. 5 lakhs and multiples thereof
  • Tick size of 1 paise must be maintained

Important Dates

  • Allotment Date: November 17, 2025
  • Listing Date: November 17, 2025
  • Redemption Date (Series 1): December 24, 2025
  • Redemption Date (Series 2): December 29, 2025

Impact Assessment

Market Impact: Minimal. This is a routine short-term debt instrument listing by one of India’s largest corporates.

Operational Impact: Trading members can now trade these commercial paper instruments on the BSE Debt segment. The instruments have very short tenures (37-42 days) and high credit ratings, indicating low risk.

Investor Impact: Provides institutional investors with short-term investment opportunities backed by Reliance Industries’ high credit quality (A1+ rating from both CARE and CRISIL).

Impact Justification

Routine commercial paper listing by a large corporate entity with no broader market implications or regulatory changes